Follow
Madhu Nath
Madhu Nath
Post Doctoral Fellow, University of Michigan
Verified email at med.umich.edu
Title
Cited by
Cited by
Year
Un-segregated waste disposal: an alarming threat of antimicrobials in surface and ground water sources in Delhi
T Velpandian, N Halder, M Nath, U Das, L Moksha, L Gowtham, SP Batta
Environmental Science and Pollution Research 25, 29518-29528, 2018
552018
Circulating biomarkers in glaucoma, age-related macular degeneration, and diabetic retinopathy
M Nath, N Halder, T Velpandian
Indian Journal of Ophthalmology 65 (3), 191-197, 2017
252017
Involvement of renin-angiotensin system in retinopathy of prematurity-a possible target for therapeutic intervention
M Nath, P Chandra, N Halder, B Singh, AK Deorari, A Kumar, R Azad, ...
PLoS One 11 (12), e0168809, 2016
202016
Evaluation of hepatic metabolism and pharmacokinetics of ibuprofen in rats under chronic hypobaric hypoxia for targeted therapy at high altitude
S Gola, A Gupta, GK Keshri, M Nath, T Velpandian
Journal of Pharmaceutical and Biomedical Analysis 121, 114-122, 2016
182016
HspB4/αA-crystallin modulates neuroinflammation in the retina via the stress-specific inflammatory pathways
M Nath, Y Shan, AM Myers, PE Fort
Journal of Clinical Medicine 10 (11), 2384, 2021
132021
A novel immunodeficient NOD.SCID-rd1 mouse model of retinitis pigmentosa to investigate potential therapeutics and pathogenesis of retinal degeneration
A Mishra, B Das, M Nath, S Iyer, A Kesarwani, J Bhattacharjee, S Arindkar, ...
Biology Open 6 (4), 449-462, 2017
122017
Peripheral blood-derived monocytes show neuronal properties and integration in immune-deficient rd1 mouse model upon phenotypic differentiation and induction with retinal …
A Mishra, KV Mohan, P Nagarajan, S Iyer, A Kesarwani, M Nath, ...
Stem Cell Research & Therapy 11, 1-17, 2020
72020
Ocular manifestations of central insulin resistance
MA Faiq, T Sengupta, M Nath, T Velpandian, D Saluja, R Dada, T Dada, ...
Neural Regeneration Research 18 (5), 1139-1146, 2023
52023
An experimental study to evaluate safety/toxicity of intravitreal natalizumab
R Chawla, M Nath, L Moksha, TC Nag, T Velpandian
Indian Journal of Ophthalmology 66 (10), 1441-1445, 2018
52018
Evidence for Paracrine Protective Role of Exogenous αA-Crystallin in Retinal Ganglion Cells
M Nath, ZB Sluzala, AS Phadte, Y Shan, AM Myers, PE Fort
Eneuro 9 (2), 2022
32022
Evaluation of the possibility of selective modulation of retinal glucose transporters in diabetic complications: An experimental study
K Mishra, M Nath, N Halder, T Velpandian
Indian Journal of Pharmacology 52 (6), 495-504, 2020
32020
Role of central insulin resistance in glaucoma
MA Faiq, T Dada, T Sengupta, M Nath, T Velpandian, K Chan
Investigative Ophthalmology & Visual Science 60 (9), 682-682, 2019
32019
Finger printing of counterfeit bevacizumab and identifying it before clinical use
T Velpandian, M Nath, M Laxmi, N Halder
The National Medical Journal of India 29 (6), 326, 2016
32016
Pharmacokinetics of Antimicrobials in Endophthalmitis
T Velpandian, M Nath
Endophthalmitis: A Guide to Diagnosis and Management, 265-280, 2018
22018
αA-Crystallin Mediated Neuroprotection in the Retinal Neurons Is Independent of Protein Kinase B
M Nath, PE Fort
Frontiers in Neuroscience 16, 912757, 2022
12022
Ocular kinetics and safety of intravitreally injected angiotensin converting enzyme inhibitor lisinopril
M Nath, N Halder, P Chandra, SB Singh, AK Deorari, A Kumar, ...
International Journal of Retina and Vitreous 4, 1-8, 2018
12018
Pharmacological Interventions for Vascular Targeting In Retinopathy of Prematurity: An Experimental Study
N Aron, M Nath, SV Azad, P Chandra, RV Azad, T Velpandian
Indian J Physiol Pharmacol 60 (3), 282-290, 2016
12016
Evaluation of intraocular penetration of Meropenem and Ertapenem after systemic administration in non-inflamed eyes
U Das, M Nath, D Chadrasekharan, R Pal, P Venkatesh, T Velpandian
INDIAN JOURNAL OF PHARMACOLOGY 46, S96-S97, 2014
12014
中枢胰岛素抵抗的眼部表现
MA Faiq, T Sengupta, M Nath, T Velpandian, D Saluja, R Dada, T Dada, ...
中国神经再生研究 (英文版) 18 (5), 1139, 2023
2023
CML-362 Study to Evaluate the Effect of Fatty Meals on Nilotinib Drug Levels in Patients of Chronic Myeloid Leukemia–Chronic Phase and Correlate Its In-Vivo Activity With STAT1 …
AN Varshney, L Moksha, M Mendiratta, RK Sahoo, PS Malik, L Kumar, ...
Clinical Lymphoma Myeloma and Leukemia 22, S293-S294, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20